
|Articles|March 11, 2021
Science 37 and Xperiome in Rare Disease Studies
Advertisement
Science 37 announced a partnership with Xperiome, a global, rare disease health tech company. The partnership furthers Science 37's capabilities to bring research to patients enabling treating physicians the opportunity to advance research as an investigator. Science 37 will leverage Xperiome's insights from Raremark, including a specialized matching engine to connect research-ready members to clinical and real-world study opportunities.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
5



